The Effect of Amoxapine and Imipramine on Serum Prolactin Levels

David S. Cooper, Alan J. Gelenberg, Joanne C. Wojcik, Velia C. Saxe, E. Chester Ridgway, Farahe Maloof

Research output: Contribution to journalArticle

Abstract

The effect of traditional tricyclic antidepressants on serum prolactin levels is controversial. In a five-week double-blind study of depressed outpatients, imipramine hydrochloride therapy did not lead to any significant change in serum prolactin levels. In contrast, amoxapine, a new antidepressant, produced significant elevations in serum prolactin levels in female and in male patients. Amoxapine may block dopamine receptors in central tuberoinfundibular pathways, which would account for its prolactin-elevating activity. On the other hand, imipramine and other traditional tricyclic antidepressants do not affect dopamine transmission, do not raise serum prolactin levels, and are not effective antipsychotic drugs.

Original languageEnglish (US)
Pages (from-to)1023-1025
Number of pages3
JournalArchives of internal medicine
Volume141
Issue number8
DOIs
StatePublished - Jul 1981
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'The Effect of Amoxapine and Imipramine on Serum Prolactin Levels'. Together they form a unique fingerprint.

  • Cite this

    Cooper, D. S., Gelenberg, A. J., Wojcik, J. C., Saxe, V. C., Ridgway, E. C., & Maloof, F. (1981). The Effect of Amoxapine and Imipramine on Serum Prolactin Levels. Archives of internal medicine, 141(8), 1023-1025. https://doi.org/10.1001/archinte.1981.00340080063015